Asim Roy
Overview
Explore the profile of Asim Roy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Roy A, Ito D, Morris S, Candler S, Profant J, Bae C
Nat Sci Sleep
. 2023 Oct;
15:767-778.
PMID: 37799734
Purpose: Real-world data regarding divided nightly dosing of oxybate and individualized prescribing in patients with narcolepsy are limited. Study objectives were to understand oxybate prescribing practices, including optimizing dose regimens...
12.
Bogan R, Roy A, Kram J, Ojile J, Rosenberg R, Hudson J, et al.
Sleep
. 2023 Jul;
46(10).
PMID: 37458698
Study Objectives: The purpose of this study was to evaluate the efficacy and safety/tolerability of bilateral high-frequency tonic motor activation (TOMAC) in patients with medication-refractory restless legs syndrome (RLS). Methods:...
13.
Roy A, Ojile J, Kram J, Olin J, Rosenberg R, Hudson J, et al.
Sleep
. 2023 Jul;
46(10).
PMID: 37439365
Study Objectives: To evaluate long-term efficacy and safety of tonic motor activation (TOMAC) for treatment of medication-refractory moderate-to-severe primary restless legs syndrome (RLS). Methods: In the parent study (RESTFUL), adults...
14.
Kent D, Huyett P, Yu P, Roy A, Mehra R, Rundo J, et al.
J Clin Sleep Med
. 2023 Jul;
19(11):1905-1912.
PMID: 37421320
Study Objectives: We conducted this study to evaluate whether laboratory or home-based hypoglossal nerve stimulation (HNS) management would have equivalent objective and subjective obstructive sleep apnea outcomes 6 months after...
15.
Dauvilliers Y, Roth T, Bogan R, Thorpy M, Morse A, Roy A, et al.
Sleep
. 2023 May;
46(11).
PMID: 37246913
Study Objectives: Post hoc analyses from the phase 3 REST-ON trial evaluated efficacy of extended-release once-nightly sodium oxybate (ON-SXB; FT218) vs placebo for daytime sleepiness and disrupted nighttime sleep in...
16.
Arnulf I, Thomas R, Roy A, Dauvilliers Y
Sleep Med Rev
. 2023 Mar;
69:101766.
PMID: 36921459
Idiopathic hypersomnia is a central hypersomnolence disorder of unknown origin characterized by excessive daytime sleepiness despite normal or long sleep time, and frequent severe sleep inertia. Management strategies have been...
17.
Kushida C, Roth T, Shapiro C, Roy A, Rosenberg R, Ajayi A, et al.
Sleep
. 2022 Jun;
45(6).
PMID: 35695179
No abstract available.
18.
Soose R, Araujo M, Faber K, Roy A, Lee K, Ni Q, et al.
Sleep
. 2022 Mar;
45(11).
PMID: 35245933
Study Objectives: Upper airway stimulation (UAS) therapy is effective for a subset of obstructive sleep apnea (OSA) patients with continuous positive airway pressure (CPAP) intolerance. While overall adherence is high,...
19.
Kushida C, Shapiro C, Roth T, Thorpy M, Corser B, Ajayi A, et al.
Sleep
. 2021 Aug;
45(6).
PMID: 34358324
Study Objectives: To assess the efficacy and safety of FT218, a novel once-nightly formulation of sodium oxybate (ON-SXB), in patients with narcolepsy in the phase 3 REST-ON trial. Methods: Narcolepsy...
20.
Siddik A, Haldar P, Paul T, Das U, Barman A, Roy A, et al.
Nanoscale
. 2021 May;
13(19):8864-8874.
PMID: 33949417
Recently, several types of lead halide perovskites have been actively researched for resistive switching (RS) memory or artificial synaptic devices due to their current-voltage hysteresis along with the feasibility of...